Loading…
Fierce JPM Week - Virtual Agenda
Attending this event?

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Tuesday, January 18
 

9:30am EST

The post-COVID supply chain
While drug supply chains generally held up during the pandemic, it was no easy feat. COVID-19 taught the industry just how vulnerable the far-flung supply chain could become, and it spawned new efforts to regionalize manufacturing and double down on automation. We’ll discuss how companies adapted to the challenges and what lessons they’ll take forward to ensure secure supply chains for the long haul.

Moderators
avatar for Kevin Dunleavy

Kevin Dunleavy

Staff Writer, Fierce Pharma
Kevin Dunleavy is a staff writer for Fierce Pharma. He joined the Fierce team after working 26 years as a newspaper sportswriter. He compiles Fierce Pharma’s COVID Tracker and writes about manufacturing and other topics. Kevin is a longtime resident of Northern Virginia and a graduate... Read More →

Speakers
avatar for Holger Weintritt, PhD

Holger Weintritt, PhD

Head of Product Supply, Bayer Pharmaceuticals
Holger has more than 20 years of industry experience in operations and supply chain. At the beginning of his career, he was a Laboratory Manager, Plant Manager, and Chief of Staff. Afterwards, he held various positions in the Supply Chain Organization of Bayer’s Crop Science business... Read More →
avatar for Kevin Cook

Kevin Cook

VP Supply Chain, North America, Sandoz
Kevin Cook serves as Vice President, Supply Chain, North America at Sandoz Inc. where he is also a member of the Sandoz US Executive Committee. With over 25 years in the life sciences industry, Kevin oversees supply for the US and Canadian generics market, including fulfillment to... Read More →
avatar for Alessandro Maselli

Alessandro Maselli

President and COO, Catalent
Alessandro Maselli was appointed Catalent’s President and Chief Operating Officer in February 2019.  Mr. Maselli joined Catalent in 2010 as Director of Operations at Catalent’s pharmaceutical, nutritional and cosmetics plant in Aprilia, Italy. In 2013, he was appointed General... Read More →
avatar for Al Boyle

Al Boyle

Chief Technical Operations and Quality Officer, Alnylam Pharmaceuticals
Al is the Chief Technical Operations and Quality Officer for Alnylam Pharmaceuticals. He leads a global organization responsible for all aspects siRNA process and analytical development, clinical and commercial manufacturing, supply chain operations, engineering, facilities and real... Read More →


Tuesday January 18, 2022 9:30am - 10:30am EST

10:30am EST

Partner Keynote
Tuesday January 18, 2022 10:30am - 10:50am EST

10:50am EST

Executive Interview: Christian Rommel, EVP, Head, Pharmaceuticals Research & Development, Bayer AG
Speakers
avatar for Christian Rommel, Ph.D.

Christian Rommel, Ph.D.

Global Head of Research & Development, Bayer Pharmaceuticals
Christian Rommel joined Bayer from Roche, where he was most recently Senior Vice President, Global Head of Oncology, Pharma Research and Early Development (pRED). Rommel also served at Amgen as Vice President of External Research and Development. Before that role, he was Amgen’s... Read More →


Tuesday January 18, 2022 10:50am - 11:10am EST

11:10am EST

Partner Presentation
Tuesday January 18, 2022 11:10am - 11:30am EST

11:30am EST

Executive Interview: Martin Meeson, Chief Executive Officer, FUJIFILM Diosynth Biotechnologies
Speakers
avatar for Martin Meeson

Martin Meeson

CEO, FUJIFILM Diosynth Biotechnologies
Martin Meeson is a seasoned executive who brings extensive global experience to the Biotech and Pharmaceutical markets.Martin was named Chief Executive Officer on April 1st, 2020, after serving as Chief Operating Officer and President of our US FDB operations (North Carolina and Texas... Read More →


Tuesday January 18, 2022 11:30am - 11:50am EST

12:00pm EST

Networking Break
Tuesday January 18, 2022 12:00pm - 1:00pm EST

1:00pm EST

New paths to trial diversity
To get drug development done through COVID-19 lockdowns and social distancing, trial sponsors turned to new technology—from data management to patient monitoring—and decentralized procedures. Those same methods could potentially help biopharma bring real diversity to future clinical trials. But hurdles to these patient-centric trials still remain. How can drugmakers clear those obstacles and tap technology to make their trials look like the patient populations who’ll use the treatments being tested? 

Moderators
avatar for Annalee Armstrong

Annalee Armstrong

Senior Editor, Fierce Biotech
Annalee Armstrong is a senior editor for Fierce Biotech. Prior to joining Fierce in April 2021, Annalee was an associate editor for S&P Global Market Intelligence’s healthcare news team. Before that, she was the EPA reporter covering climate and energy policy on the Hill in Washington... Read More →

Speakers
avatar for Keiki Oishi

Keiki Oishi

President and COO, CMIC Group
Ms. Oishi is the President and COO of CMIC HOLDINGS Co., Ltd., responsible for group-wide business execution.Ms. Oishi received her Master of Science degree from the University of Tokyo. She started her career at Nikkei McGraw-Hill, Inc. in Japan (now renamed Nikkei Business Publications... Read More →
avatar for Gregory Rotz

Gregory Rotz

Principal, PwC US
Greg Rotz is a Principal with PwC and leads the transformation consulting practice focused on Pharmaceuticals and Life Sciences (PLS). He brings nearly 25 years of experience shaping and serving the C-suite agenda for his clients.In his sector leadership role, Greg’s focus is to... Read More →
avatar for Craig Tendler, M.D.

Craig Tendler, M.D.

Global Head, Late-Stage Clinical Development, Diagnostics & Medical Affairs, Hematology & Oncology, Janssen
Craig Tendler, M.D. is Vice President, Oncology Clinical Development and Global Medical Affairs at Janssen Research & Development, LLC. In this position, he is responsible for creating robust development plans and data generation activities for all therapies in the oncology portfolio... Read More →


Tuesday January 18, 2022 1:00pm - 2:00pm EST

2:00pm EST

Executive Interview: Alessandro Maselli, President and COO, Catalent
Speakers
avatar for Alessandro Maselli

Alessandro Maselli

President and COO, Catalent
Alessandro Maselli was appointed Catalent’s President and Chief Operating Officer in February 2019.  Mr. Maselli joined Catalent in 2010 as Director of Operations at Catalent’s pharmaceutical, nutritional and cosmetics plant in Aprilia, Italy. In 2013, he was appointed General... Read More →


Tuesday January 18, 2022 2:00pm - 2:20pm EST

2:20pm EST

Executive Interview: Kevin Ali, CEO, Organon
Speakers
avatar for Kevin Ali

Kevin Ali

CEO, Organon
Kevin Ali is the CEO and board member of Organon, a global healthcare company with the vision of creating a better and healthier every day for every woman around the world. Kevin led the formation of Organon in 2021 to address the significant health issues that women face and deliver... Read More →


Tuesday January 18, 2022 2:20pm - 2:40pm EST

2:40pm EST

Challenge the rules of security: Transform the threat surface to proactive control
We’ve seen a dramatic increase in distributed workforce, telehealth and usage of cloud applications across healthcare providers. And healthcare organizations continue to be targeted by cybercriminals, and now with remote endpoints, they have more ways to break in than ever before. Historically, endpoint security has been a zero-sum game—with the odds inevitably stacked against IT. But rather than protecting devices, what if you could control their security ahead of time?

In this session, see how Chrome OS and Chrome Browser are secure by design—embedding security into every workflow to provide proactive protection for your staff, devices, applications, and patient information, wherever work happens. This is cloud-first security that will help healthcare providers thrive moving forward.

Speakers
avatar for Mike Puzen

Mike Puzen

Head of GTM, Chrome Enterprise, Google
Mike has been a technology thought leader for the past 15 years. He has focused on Retail, Manufacturing and Healthcare for most of his career with IBM, Sandisk, Lenovo and now Google. The goal for him has always been to push the boundaries of innovation at the customer experience... Read More →


Tuesday January 18, 2022 2:40pm - 3:00pm EST

3:00pm EST

CEO Presentation
Tuesday January 18, 2022 3:00pm - 3:15pm EST

3:15pm EST

CEO Presentation
Speakers
avatar for Dr. Namyong Kim

Dr. Namyong Kim

CEO, Curiox
To inspire change, one must see past tomorrow. Curiox co-founder Dr. Namyong Kim executes this as the CEO and lead inventor. At Curiox since 2008, he has grown a spin-off project from A*STAR in Singapore to a company headquartered in Seoul, Korea with operations worldwide. Under his... Read More →


Tuesday January 18, 2022 3:15pm - 3:30pm EST

3:30pm EST

Executive Interview: John V. Olyer, Chief Executive Officer, BeiGene
Speakers
avatar for John V. Oyler

John V. Oyler

CEO, BeiGene
John V. Oyler is the Co-Founder and Chairman of BeiGene and has served as Chief Executive Officer and a member of the Board of Directors since 2010. From 2005 to 2009, Mr. Oyler served as President and Chief Executive Officer of BioDuro, LLC, a drug discovery outsourcing company... Read More →


Tuesday January 18, 2022 3:30pm - 3:50pm EST
 
Wednesday, January 19
 

9:30am EST

The next mRNA wave
Biotechs had been laboring for years on mRNA drug research, but the work took a major leap forward with the approval of the Moderna and Pfizer/BioNTech COVID-19 vaccines. Their success has revved up mRNA programs at more than a dozen companies working on mRNA vaccines and treatments for a range of diseases from flu to cystic fibrosis. The market opportunity is huge, and Big Pharma is hungry for promising companies to snap up or make licensing deals with. We’ll look at the new landscape. 

Wednesday January 19, 2022 9:30am - 10:30am EST

10:30am EST

Partner Keynote
Wednesday January 19, 2022 10:30am - 10:50am EST

10:50am EST

Executive Interview: Doug Langa, Executive Vice President, North America Operations and President, Novo Nordisk Inc.
Speakers
DL

Doug Langa

Executive Vice President, North America Operations and President, Novo Nordisk Inc.


Wednesday January 19, 2022 10:50am - 11:10am EST

11:10am EST

Partner Presentation
Speakers
avatar for Jeremy Schroeder

Jeremy Schroeder

Sr. Director, Global Commercial OEM, Thermo Fisher Scientific
Jeremy Schroeder is the Sr. Director, Global Commercial OEM for Thermo Fisher Scientific. His professional passion is helping our diagnostics, life science, and therapeutic customers accelerate product development timelines, develop the best technologies, and maximize revenue by leveraging... Read More →


Wednesday January 19, 2022 11:10am - 11:30am EST

11:30am EST

Executive Interview: Ariel Katz, Co-Founder & CEO, H1
Speakers
avatar for Ariel Katz

Ariel Katz

Co-Founder & CEO, H1
Ariel started his first company in college, ResearchConnection, to help connect students with research opportunities. That company grew to over 40 universities and was eventually acquired by the Jefferson Accelerator Fund, Bill and Melinda Gates Foundation and the Ewing Kauffman Foundation. Next... Read More →


Wednesday January 19, 2022 11:30am - 11:50am EST

12:00pm EST

Networking Break
Wednesday January 19, 2022 12:00pm - 1:00pm EST

1:00pm EST

Collaboration 2022 Style
Moderators
avatar for Eric Sagonowsky

Eric Sagonowsky

Senior Editor, Fierce Pharma
Eric Sagonowsky is an editor with the FierceMarkets Life Sciences team. Before joining Fierce in November 2014, Eric worked as a news reporter for the Manistee News Advocate in Manistee, Mich., covering government and crime issues. Eric graduated from Ohio University's E.W. Scripps... Read More →

Speakers
avatar for Marianne De Backer, MSc, PhD, MBA

Marianne De Backer, MSc, PhD, MBA

Chief Business Officer, EVP, Head of Pharmaceuticals Strategy, Business Development & Licensing & Open Innovation and Member of Executive Committee, Bayer Pharmaceuticals
Marianne De Backer is a strategist, scientist, business leader, deal maker, and corporate investor in the healthcare industry. She has more than two decades of experience, and a network that spans across pharmaceutical, biotech, tech, academia, VC, NGO, and government partners worldwide... Read More →
avatar for Angus Grant

Angus Grant

Chief Business Officer, BeiGene
Angus Grant, Ph.D. joined BeiGene in June 2020 as Chief Business Executive, bringing in more than 25 years of experience across multiple key functions in the biotech industry, including business development, alliance management, research and development, and regulatory affairs . In... Read More →
avatar for Cristin Hubbard

Cristin Hubbard

Global Head of Diagnostics Partnering, Roche
Cristin Hubbard is responsible for bringing external innovation into the Roche Diagnostics Group. In her role as Global Head of Diagnostics Partnering, Cristin is a member of the Diagnostics Leadership Team based at Roche’s Headquarters in Basel.  Having grown up in California... Read More →


Wednesday January 19, 2022 1:00pm - 2:00pm EST

2:00pm EST

Executive Interview
Wednesday January 19, 2022 2:00pm - 2:20pm EST

2:20pm EST

Executive Interview: Melinda Richter, Global Head, Johnson & Johnson Innovation - JLABS
Speakers
avatar for Melinda Richter

Melinda Richter

Global Head, Johnson & Johnson Innovation – JLABS
Melinda Richter is the champion for entrepreneurs and startups, who drive potential breakthrough ideas and approaches to address unmet medical needs and combat public health threats and unmet medical needs of today, and those imagined and unimagined of tomorrow. She founded Johnson... Read More →


Wednesday January 19, 2022 2:20pm - 2:40pm EST

2:40pm EST

Partner Presentation
Wednesday January 19, 2022 2:40pm - 3:00pm EST

3:00pm EST

CEO Presentation
Wednesday January 19, 2022 3:00pm - 3:15pm EST

3:15pm EST

Executive Presentation: Shirin Hasan, Associate Vice President, Head of Global Clinical Affais, Agilent Technologies
Speakers
avatar for Shirin Hasan

Shirin Hasan

Associate Vice President, Head of Global Clinical Affairs, Agilent Technologies
Shirin Hasan is a seasoned executive in the healthcare industry, with proven leadership and in-depth experience in bringing a concept to market to improve the quality of patient lives. Shirin's career spanning over 25 years in medical diagnostics, therapeutics and biotech, has included... Read More →


Wednesday January 19, 2022 3:15pm - 3:30pm EST

3:30pm EST

Executive Interview: Kenneth Hillan, Head of Therapeutics, 23andMe
Speakers
avatar for Kenneth Hillan

Kenneth Hillan

Head of Therapeutics, 23andMe


Wednesday January 19, 2022 3:30pm - 3:50pm EST
 
Thursday, January 20
 

9:30am EST

As virtual-first plans proliferate, are they here to stay?
Multiple major payers have launched plans that put virtual care front and center, or are at the very least significantly expanding their virtual care options in the wake of COVID-19. But are these plans really here for the long haul? What does it take to balance a virtual care focus with access to in-person care? Hear from industry experts about what’s next for these plans.

Moderators
avatar for Paige Minemyer

Paige Minemyer

Senior Editor, Fierce Health Payer
Paige Minemyer is a senior editor at Fierce Healthcare, overseeing the team’s coverage of payer trends and news from across the country. Since joining the Fierce team, she’s covered the spectrum of the healthcare industry, including providers, technology and policy, and prior... Read More →

Speakers
JD

Jill Dailey

Vice President, Commercial Product, Aetna
avatar for Shawna Dodds

Shawna Dodds

Vice President of Product Development, Cigna
avatar for Kelly Bliss

Kelly Bliss

President of US Group Health, Teladoc Health
Kelly Bliss is President of U.S. Group Health. She oversees sales, client management, client and commercial operations for the business.Ms. Bliss has strong expertise in creating cohesive client-focused organizations. Most recently, she held the position of chief client officer at... Read More →


Thursday January 20, 2022 9:30am - 10:30am EST

10:30am EST

Partner Keynote
Thursday January 20, 2022 10:30am - 10:50am EST

10:50am EST

Executive Interview
Thursday January 20, 2022 10:50am - 11:10am EST

11:10am EST

Partner Presentation
Thursday January 20, 2022 11:10am - 11:30am EST

11:30am EST

Executive Interview
Thursday January 20, 2022 11:30am - 11:50am EST

12:00pm EST

Networking Break
Thursday January 20, 2022 12:00pm - 1:00pm EST

1:00pm EST

2:00pm EST

Executive Interview
Thursday January 20, 2022 2:00pm - 2:20pm EST

2:20pm EST

Executive Interview
Thursday January 20, 2022 2:20pm - 2:40pm EST

2:40pm EST

Partner Presentation
Thursday January 20, 2022 2:40pm - 3:00pm EST

3:00pm EST

CEO Presentation
Thursday January 20, 2022 3:00pm - 3:15pm EST

3:15pm EST

CEO Presentation
Speakers
avatar for David A. Ricks

David A. Ricks

Chairman and CEO, Eli Lilly and Company
Dave Ricks is chairman and chief executive officer of Eli Lilly and Company. He became CEO in January 2017 and was elected chairman of the company’s board effective June 2017.A Lilly veteran for more than 20 years, Dave served as president of Lilly Bio Medicines from 2012 to 2016... Read More →


Thursday January 20, 2022 3:15pm - 3:30pm EST

3:30pm EST

Executive Interview
Thursday January 20, 2022 3:30pm - 3:50pm EST